Caballero A.C., Escribà-Garcia L., Pujol-Fernández P., Escudero-López E., Ujaldón-Miró C., Montserrat-Torres R., Sierra J., Alvarez-Fernández C., Briones J.. High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion. CANCER GENE THERAPY. 2023; 30(1)DOI:10.1038/s41417-022-00518-6. PMID:36031661. IF:4.800(Q1/2D).

Del Principe, MI, Seidel, D, Criscuolo, M, Dargenio, M, Racil, Z, Piedimonte, M, Marchesi, F, Nadali, G, Koehler, P, Fracchiolla, N, Cattaneo, C, Klimko, N, Spolzino, A, Karapinar, DY, Demiraslan, H, Duarte, RF, Demeter, J, Stanzani, M, Melillo, LMA, Basilico, CM, Cesaro, S, Paterno, G, Califano, C, Delia, M, Buzzatti, E, Busca, A, Cornely, OA, Pagano, L, Alakel, N, Arsenijevi'c, VA, Camus, V, Falces-Romero, I, Itzhak, L, Kouba, M, Martino, R, Sedlacek, P, Weinbergerova, B. Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope. MYCOSES. 2023; 66(1)DOI:10.1111/myc.13524. PMID:36064299. IF:4.100(Q1/2D).

Barba, P, Morgades, M, Montesinos, P, Gonzalez-Campos, J, Torrent, A, Gil, C, Bernal, T, Tormo, M, Mercadal, S, Novoa, S, Garcia-Cadenas, I, de Llano, MPQ, Cervera, M, Coll, R, Bermudez, A, Amigo, ML, Monsalvo, S, Esteve, J, Garcia-Boyero, R, Novo, A, Rivas, JMH, Cladera, A, Martinez-Sanchez, P, Serrano, J, Artola, MT, Soria, B, Abella, E, Vall-Llovera, F, Bergua, J, Herrera, P, Barrios, D, Ribera, JM. Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols. Hemasphere. 2023; 7(1)DOI:10.1097/HS9.0000000000000810. PMID:36583094. IF:11.900(Q1/1D).

Caballero A.C., Escribà-Garcia L., Pujol-Fernández P., Escudero-López E., Ujaldón-Miró C., Montserrat-Torres R., Sierra J., Alvarez-Fernández C., Briones J.. High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion (vol 30, pg 51, 2023). CANCER GENE THERAPY. 2023; 30(1)DOI:10.1038/s41417-022-00564-0. PMID:36460806. IF:4.800(Q1/2D).

Cruz D., Rodríguez-Romanos R., González-Bartulos M., García-Cadenas I., de la Cámara R., Heras I., Buño I., Santos N., Lloveras N., Velarde P., Tuset E., Martínez C., González M., Sanz G.F., Ferrá C., Sampol A., Coll R., Pérez-Simón J.A., López-Jiménez J., Jurado M., Gallardo D.. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1066393. PMID:36742309. IF:5.700(Q1/3D).

Kwon M., Iacoboni G., Reguera J.L., López Corral L., Morales R.H., Ortiz-Maldonado V., Guerreiro M., Caballero A.C., Domínguez M.L.G., Pina J.M.S., Mussetti A., Sancho J.M., Bastos-Oreiro M., Catala E., Delgado J., Henriquez H.L., Sanz J., Calbacho M., Bailén R., Carpio C., Ribera J.M., Sureda A., Briones J., Hernandez-Boluda J.C., Cebrián N.M., Martin J.L.D., Martín A., Barba P.. Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma. HAEMATOLOGICA. 2023; 108(1)DOI:10.3324/haematol.2022.280805. PMID:35770532. IF:10.100(Q1/2D).

Dickinson M.J., Barba P., Jäger U., Shah N.N., Blaise D., Briones J., Shune L., Boissel N., Bondanza A., Mariconti L., Marchal A.-L., Quinn D.S., Yang J., Price A., Sohoni A., Treanor L.M., Orlando E.J., Mataraza J., Davis J., Lu D., Zhu X., Engels B., Moutouh-de Parseval L., Brogdon J.L., Moschetta M., Flinn I.W.. A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development. Cancer Discovery. 2023; 13(9)DOI:10.1158/2159-8290.CD-22-1276. PMID:37249512. IF:30.600(Q1/1D).

Solano C., Castro-Rebollo P., Pérez-Martínez A., López-Corral L., Barba-Suñol P., Kwon M., Ortiz V., Sanz-Caballer J., Caballero A.C., Martínez J., Cedillo Á., Sureda A.. Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: A survey-based study. BMJ Open. 2023; 13(7)DOI:10.1136/bmjopen-2022-071371. PMID:37491085. IF:2.400(Q1/3D).

Muñoz A., Ay C., Grilz E., López S., Font C., Pachón V., Castellón V., Martínez-Marín V., Salgado M., Martínez E., Calzas J., Ortega L., Rupérez A., Salas E., Pabinger I., Soria J.M.. A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts. JOURNAL OF CLINICAL ONCOLOGY. 2023; 41(16)DOI:10.1200/JCO.22.00255. PMID:36730884. IF:42.100(Q1/1D).

García-Calderón C.B., Sierro-Martínez B., García-Guerrero E., Sanoja-Flores L., Muñoz-García R., Ruiz-Maldonado V., Jimenez-Leon M.R., Delgado-Serrano J., Molinos-Quintana Á., Guijarro-Albaladejo B., Carrasco-Brocal I., Lucena J.-M., García-Lozano J.-R., Blázquez-Goñi C., Reguera-Ortega J.L., González-Escribano M.-F., Reinoso-Segura M., Briones J., Pérez-Simón J.A., Caballero-Velázquez T.. Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1152498. PMID:37122702. IF:5.700(Q1/3D).

Olive-Gadea, M, de la Ossa, NP, Jovin, T, Abilleira, S, Jimenez, X, Cardona, P, Chamorro, A, Flores, A, Silva, Y, Purroy, F, Marti-Fabregas, J, Rodriguez-Campello, A, Zaragoza, J, Krupinski, J, Canovas, D, Choco, MG, Mas, N, Palomeras, E, Cocho, D, Aragones, JM, Repullo, C, Sanjurjo, E, Carrion, D, Catena, E, Costa, X, Almendros, MC, Barcelo, M, Monedero, J, Rybyeva, M, Diaz, G, Ribo, M. Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population. International Journal of Stroke. 2023; 18(2)DOI:10.1177/17474930221093523. PMID:35373657. IF:6.300(Q1/1D).

Terceno, M, Silva, Y, Bashir, S, Chamorro, A, de la Ossa, NP, Hernandez-Perez, M, Castano, C, Camps-Renom, P, Wenger, D, Cardona, P, Molina, C, Rodriguez-Campello, A, Canovas, D, Purroy, F, Salvat-Plana, M, Serena, J. First pass effect in posterior circulation occlusions: Analysis from the CICAT registry. International Journal of Stroke. 2023; 18(2)DOI:10.1177/17474930221089772. PMID:35272563. IF:6.300(Q1/1D).

Puig N., Rives J., Estruch M., Aguilera-Simon A., Rotllan N., Camacho M., Colomé N., Canals F., Sánchez-Quesada J.L., Benitez S.. Presence of Ceramidase Activity in Electronegative LDL. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(1)DOI:10.3390/ijms24010165. PMID:36613609. IF:4.900(Q1/3D).

Amalia B., Fu M., Tigova O., Ballbè M., Paniello-Castillo B., Castellano Y., Vyzikidou V.K., O'Donnell R., Dobson R., Lugo A., Veronese C., Pérez-Ortuño R., Pascual J.A., Cortés N., Gil F., Olmedo P., Soriano J.B., Boffi R., Ruprecht A., Ancochea J., López M.J., Gallus S., Vardavas C., Semple S., Fernández E.. Exposure to secondhand aerosol from electronic cigarettes at homes: A real-life study in four European countries. The Science of the total environment. 2023; 854DOI:10.1016/j.scitotenv.2022.158668. PMID:36099951. IF:8.200(Q1/1D).

Castillo J.A., Plaza V., Rodrigo G., Juliá B., Picado C., Fernández C., Mullol J.. Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma. Journal Of Allergy And Clinical Immunology: Global. 2023; 2(4)DOI:10.1016/j.jacig.2023.100134. PMID:37781668. IF:(Q/D).

Corominas H., Young D., Cummings J.R.F., Bouhnik Y., Armuzzi A., Thaci D., Kim J.. Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review. CLINICAL DRUG INVESTIGATION. 2023; 43(8)DOI:10.1007/s40261-023-01284-5. PMID:37615857. IF:(Q/D).

Sarasate M., González N., Córdoba-Izquierdo A., Prats E., Gonzalez-Moro, JMR, Martí S., Lujan M., Calle M., Antón A., Povedano M., Farrero E.. Impact of Early Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A multicenter Randomized Controlled Trial. Journal Of Neuromuscular Diseases. 2023; 10(4)DOI:10.3233/JND-221658. PMID:37212068. IF:3.200(Q2/3D).

López-López D., Roldán G., Fernández-Rueda J.L., Bostelmann G., Carmona R., Aquino V., Perez-Florido J., Ortuño F., Pita G., Núñez-Torres R., González-Neira A., Alonso A., Salgado-Garrido J., Pasalodos-Sanchez S., Ayuso C., Minguez P., Avila-Fernandez A., Corton M., Artuch R., Borrego S., Antiñolo G., Carracedo A., Amigo J., Castaño L.A., Tejada I., Delmiro A., Espinos C., Grinberg D., Guillén E., Lapunzina P., Lopez-Escámez J.A., Gallego-Martinez A., Martí R., Rovira E., Millán J.M., Moreno M.A., Morin M., Moreno-Galdó A., Fernández-Cancio M., Morte B., Mulero V., García D., Nunes V., Palau F., Perez B., Jurado L.P., Perona R., Pujol A., Ramos F., Lopez E., Ribes A., Rosell J., Surrallés J., Peña-Chilet M., Dopazo J.. A crowdsourcing database for the copy-number variation of the Spanish population. Human Genomics. 2023; 17(1)DOI:10.1186/s40246-023-00466-8. PMID:36894999. IF:3.800(Q2/3D).

Bertran-Alamillo J., Giménez-Capitán A., Román R., Talbot S., Whiteley R., Floc’h N., Martínez-Pérez E., Martin M.J., Smith P.D., Sullivan I., Terp M.G., Saeh J., Marino-Buslje C., Fabbri G., Guo G., Xu M., Tornador C., Aguilar-Hernández A., Reguart N., Ditzel H.J., Martínez-Bueno A., Nabau-Moretó N., Gascó A., Rosell R., Pease J.E., Polanska U.M., Travers J., Urosevic J., Molina-Vila M.A.. BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors. Molecular Cancer. 2023; 22(1)DOI:10.1186/s12943-023-01815-w. PMID:37443114. IF:27.700(Q1/1D).

Blanco R., Dómine M., González J.L., Loutfi S., Alfaro J., Saldaña J., Rubio J., Campos B., Hidalgo J., Barba A., Márquez D., Martin M., Olaverri A., Nadal E.. Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes. LUNG CANCER. 2023; 183DOI:10.1016/j.lungcan.2023.107318. PMID:37557022. IF:4.500(Q1/2D).